2018 Peter Barry Fellowship winner

This Fellowship commemorates the immense contribution made to ophthalmology by former ESCRS president Peter Barry.

2018 Peter Barry Fellowship winner
Colin Kerr
Colin Kerr
Published: Friday, December 7, 2018
Andreas Frings with ESCRS President Beatrice Cochener-Lamar
Andreas Frings with ESCRS President Beatrice Cochener-Lamar

The winner of this year’s Peter Barry Fellowship is Andreas Frings. Peter Barry was among the pioneers who laid the foundation of the ESCRS and served there for more than 25 years as a board member, treasurer and president. He also had a major role in bringing ESCRS academies around the world. The Fellowship of €60,000 is to allow a trainee to work at a centre of excellence for clinical experience or research in cataract and refractive surgery, for one year, anywhere in the world. Dr Frings studied medicine at medical schools in Hamburg, Germany, and Graz, Austria. He started his training in ophthalmology in 2013 at University Hospital Hamburg, Germany, and finished his training in May 2018 (working at University Hospital Düsseldorf, Germany). He also passed his national exam and EBO exam in May 2018. “Since my MD thesis in 2011, I have been focusing on issues related to cataract and refractive surgery, including topics dealing with biometry, astigmatism treatment and vector analysis, laser refractive surgery and interdisciplinary topics related to corneal biomechanics,” said Dr Frings. He has published more than 50 studies as first, last or co-author and has been involved in more than 100 presentations as first, last or co-author. “I am happy to serve as a supervisor of many younger colleagues and students doing their MD thesis,” said Dr Frings. Dr Frings started his Peter Barry Fellowship in August 2018 at Moorfields Eye Hospital, Refractive Surgery Service, under the supervision of Mr Bruce Allan. His project involves the psychometric evaluation and calibration of a novel patient-reported outcome (PRO) measure for refractive surgery patients developed for use as part of the National Dataset in Refractive Surgery. “We build on existing measures and will use contemporary questionnaire development and validation methodology, including Rasch fitting, to provide a thorough evaluation of the psychometric properties of the new questionnaire,” he said. The development and validation of a concise, practical, online, self-administered, self-archiving and self-scoring PRO questionnaire for routine clinical use in refractive surgery is the primary study objective. Secondary objectives are to gather outcome data from patients before and after surgery in each of the following domains comprising key elements of vision-related quality of life: spectacle dependence; quality of vision; eye comfort; freedom; emotional well-being; and overall satisfaction with the results of surgery. Andreas Frings: 
andi.frings@gmail.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...